Terminated PHASE3 INTERVENTIONAL 2-arm NCT01439347

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Phase 3 Study of Study to Evaluate Marqibo® in the Combination Chemotherapy in the Treatment of Subjects >or=60 Years Old With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Sponsor: Spectrum Pharmaceuticals, Inc

Conditions Acute Lymphoblastic Leukemia (ALL)

Interventions Vincristine Sulfate Injection (VSI) Vincristine Sulfate Liposomes Injection (VSLI)

Updated 8 times since 2017 Last updated: Sep 6, 2021 Started: Mar 31, 2012 Primary completion: Nov 30, 2015 Completion: Nov 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor decision

Other terminated trials from Spectrum Pharmaceuticals, Inc

More terminations from Spectrum Pharmaceuticals, Inc

A PHASE3 clinical study on Acute Lymphoblastic Leukemia (ALL), this trial is terminated or withdrawn. The trial is conducted by Spectrum Pharmaceuticals, Inc and has accumulated 8 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE3
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Oct 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jan 2021 — Oct 2021 [monthly]

Terminated PHASE3

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE3
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE3

First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Spectrum Pharmaceuticals, Inc

Data source: Spectrum Pharmaceuticals, Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Buffalo, United States , Chicago, United States , Cleveland, United States , Detroit, United States , Durham, United States , Hackensack, United States , Houston, United States , La Jolla, United States , Los Angeles, United States and 4 more locations